You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 1, January 1983 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Biologic behavior of thin malignant melanomas with regressive changes

R. R. Paladugu and R. H. Yonemoto

Thin cutaneous malignant melanomas are defined as lesions measuring less than 0.76 mm in maximal thickness. Eight of the 36 thin lesions that we studied metastasized within two to 120 months. Of the 11 lesions with regressive features, five (45.5%) metastasized. Of 25 lesions without regression, only three (12%) metastasized. Thin melanomas with regressive changes need to be reported as a separate category because of their propensity to metastasize. Conventional prognostic guidelines for treatment of thin melanomas are not applicable to this type of lesion. Clinicians need to be cognizant that regressive changes are serious warning signals when they occur in thin melanomas.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The correlation of regression in primary melanoma with sentinel lymph node status
Kaur et al.
J. Clin. Pathol. 2008;61:297-300.
ABSTRACT | FULL TEXT  

Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Lowe et al.
Arch Dermatol 2003;139:617-621.
ABSTRACT | FULL TEXT  

Histological Characteristics of Metastasizing Thin Melanomas: A Case-Control Study of 43 Cases
Guitart et al.
Arch Dermatol 2002;138:603-608.
ABSTRACT | FULL TEXT  

Thin Melanomas and Regression, Thick Melanomas and Older Men: Prognostic Implications and Perspectives on Secondary Prevention
Demierre
Arch Dermatol 2002;138:678-682.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1983 American Medical Association. All Rights Reserved.